Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Classic Hodgkin Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05162976
What this trial is testing

CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed

Who this might be right for
Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
City of Hope Medical Center 33
Not applicableWithdrawnNCT00093678
What this trial is testing

Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer

Who this might be right for
CachexiaLymphomaMelanoma (Skin)+4 more
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT05821088
What this trial is testing

Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma

Who this might be right for
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedRecurrent Grade 3b Follicular Lymphoma+19 more
David Bond, MD
Testing effectiveness (Phase 2)Study completedNCT05140382
What this trial is testing

AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL

Who this might be right for
Relapsed/Refractory Peripheral T-cell LymphomaRelapsed/Refractory Classical Hodgkins Lymphoma
AstraZeneca 52
Testing effectiveness (Phase 2)Ended earlyNCT05255601
What this trial is testing

Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHodgkin Disease
Bristol-Myers Squibb 5
Testing effectiveness (Phase 2)UnknownNCT05896046
What this trial is testing

SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Hodgkin Lymphoma
Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03057795
What this trial is testing

Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma

Who this might be right for
Classic Hodgkin LymphomaRecurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
City of Hope Medical Center 62
Testing effectiveness (Phase 2)Ended earlyNCT04788043
What this trial is testing

Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaClassic Hodgkin LymphomaRelapsed Classical Hodgkin Lymphoma+1 more
Ranjana Advani 8
Testing effectiveness (Phase 2)Study completedNCT04074746
What this trial is testing

Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas

Who this might be right for
Recurrent Anaplastic Large Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Classic Hodgkin Lymphoma+7 more
M.D. Anderson Cancer Center 45
Large-scale testing (Phase 3)UnknownNCT05518318
What this trial is testing

GLS-010 Monotherapy Versus Chemotherapy in Patients With Relapsed or Refractory Classical Hodgkin's Lymphoma (R/R cHL)

Who this might be right for
Classic Hodgkin's LymphomaRecurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
Guangzhou Gloria Biosciences Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT05757466
What this trial is testing

Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University 30
Testing effectiveness (Phase 2)UnknownNCT03655483
What this trial is testing

Study of GLS-010 Injection in the Treatment of Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin's Lymphoma
Guangzhou Gloria Biosciences Co., Ltd. 85
Testing effectiveness (Phase 2)UnknownNCT04026269
What this trial is testing

Clinical Efficacy of MOAP Regimen for Relapsed/Refractory cHL as a Rescue Therapy After DP Regimen

Who this might be right for
Hodgkin Lymphoma
Han weidong 30
Early research (Phase 1)Active Not RecruitingNCT03150329
What this trial is testing

Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.

Who this might be right for
Grade 3b Follicular LymphomaRecurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic HLRecurrent Classic Hodgkin Lymphoma+13 more
City of Hope Medical Center 52
Not applicableStudy completedNCT03766516
What this trial is testing

Registry of BrentuximabVedotinin Patients With R/R Anaplastic Large Cell Lymphoma or Classical HL

Who this might be right for
Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
Samsung Medical Center 90
Early research (Phase 1)Study completedNCT01950364
What this trial is testing

Study in Patients With Relapsed or Refractory Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

Who this might be right for
Hodgkin LymphomaAnaplastic Large-cell Lymphoma
Millennium Pharmaceuticals, Inc. 20
Early research (Phase 1)Active Not RecruitingNCT05352828
What this trial is testing

Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy

Who this might be right for
Classical Hodgkin LymphomaHodgkin Disease RefractoryHodgkin Disease Recurrent
Tessa Therapeutics 15
Early research (Phase 1)Ended earlyNCT02603419
What this trial is testing

Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)

Who this might be right for
Hodgkins Lymphoma
Pfizer 34
Not applicableStudy completedNCT02815137
What this trial is testing

Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Centre Henri Becquerel 137
Not applicableUnknownNCT04237233
What this trial is testing

Intense Monitoring Study on Tyvyt

Who this might be right for
Relapsed or Refractory Classical Hodgkin's Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 300
Next Page
37